Malarone Adult Tablet contains Atovaquone 250 mg and Proguanil Hydrochloride 100 mg per tablet. It is indicated for the treatment of uncomplicated malaria and the prevention (prophylaxis) of malaria in adults and adolescents weighing over 40 kg, particularly in areas where Plasmodium falciparum is resistant to other antimalarials.

Atovaquone works by disrupting parasite energy production, while Proguanil interferes with parasite DNA synthesis. Together, they provide strong dual protection—clearing active malaria infections and preventing new infections. Its once-daily dosing makes it a convenient and well-tolerated choice for both travelers and residents in malaria-endemic regions.

Key Benefits:

• Effective Combination: Atovaquone 250 mg + Proguanil 100 mg for powerful malaria protection.
• Dual Purpose: Suitable for both treatment and prevention of malaria.
• Once-Daily Dosing: Convenient regimen for better adherence.
• Trusted Worldwide: Recommended for travelers and residents in areas with drug-resistant malaria.

How to Use:

Take the tablets exactly as prescribed by your healthcare provider, with food or a milky drink.

• For treatment: Once daily for 3 consecutive days.
• For prevention: Start 1–2 days before entering a malaria area, continue daily during the stay, and for 7 days after leaving. Always complete the full prescribed course.